The Early Detection of Cancer Conference (EDx25) was held October 21–23, 2025 in Portland, Oregon, USA. Presented by Cancer Research UK, the Canary Center at Stanford, and the OHSU Knight Cancer Institute, the meeting brought together researchers, clinicians, technologists, and public health leaders to translate cutting-edge discovery into real-world early detection.
Across sessions, speakers highlighted the role of artificial intelligence, innovative technologies, and the practical work of getting early detection into the community and primary care—so clinicians can focus testing and follow-up on the people who need it most.
Key highlights from EDx25
Long-term registry follow-up for MCED in symptomatic patients
One major update featured long-term data from the SYMPLIFY study (GRAIL and the University of Oxford), evaluating the Galleri multi-cancer early detection (MCED) test in symptomatic individuals.
- With follow-up extended to 24 months in national cancer registries, the positive predictive value (PPV) increased to 84.2% (up from 75.5%).
- About one-third of participants initially considered “false positive” were later diagnosed with cancer during extended follow-up.
- These results reinforce the test’s ability to predict the cancer signal origin and the value of longer-term outcome capture when evaluating early detection tools.
Innovation across AI, biomarkers, and liquid biopsy
The agenda emphasized how new technologies—and the way we evaluate them—can accelerate early detection while supporting clinical adoption. Talks highlighted:
- How AI can support detection, triage, and decision-making across screening and diagnostic pathways.
- Emerging biomarker strategies and assay designs aimed at improving early-stage sensitivity and specificity.
- Implementation-oriented research focused on pathways that work in real care settings.
DNA methylation signals that sharpen colorectal cancer detection
Research presented at EDx25 demonstrated that distinguishing between DNA methylation types 5mC and 5hmC can significantly enhance the diagnostic accuracy of liquid biopsy tests for early-stage colorectal cancer (AUC = 0.95).
Primary care integration and community impact
A recurring theme was the importance of moving early detection strategies into community and primary care settings—where most patients first present—so that risk-informed tools and pathways can help identify who should receive further testing.
Collaboration across disciplines and institutions
Hosted by Cancer Research UK, the Canary Center at Stanford, and the OHSU Knight Cancer Institute, EDx25 underscored international, multidisciplinary collaboration as essential for progress in early detection—bringing together experts in research, clinical practice, engineering, and public health to accelerate translation and improve outcomes through earlier diagnosis.
Learn more about the Early Detection of Cancer Conference at earlydetectionresearch.com.
About Renata Barnes
Renata Barnes is a science communications specialist at the Canary Foundation, dedicated to sharing breakthrough research in early cancer detection.